Siemens Healthcare Diagnostics Inc.

Siemens Healthcare Diagnostics Inc., a wholly owned subsidiary of Siemens Medical Solutions USA Inc., operates as a prime contractor supplying laboratory analyzers, in vitro diagnostic reagents, consumables, and cost-per-reportable-result testing services to federal healthcare agencies on a full-and-open, unrestricted basis without set-aside protection. Headquartered in Tarrytown, New York, and classified as a foreign-owned for-profit entity under parent company Siemens Aktiengesellschaft, the vendor competes across NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and 325414 (Analytical Laboratory Instrument Manufacturing), with substantial presence in PSC categories for laboratory equipment, diagnostic substances, and reference testing services.

Siemens Healthcare Diagnostics maintains an exceptionally large federal footprint: 8,537 prime awards valued at $3.9 billion (combined potential value) across 87 distinct customer agencies over the past five years, with annual prime award volume averaging 219 awards per year. The vendor's customer base concentrates heavily within the Veterans Health Administration, which drives roughly 62 percent of potential value. The top five customers by potential value are Veterans Integrated Service Network 12 ($1.39 billion across 443 awards), VISN 10 ($556.5 million across 445 awards), VISN 6 ($198.9 million across 229 awards), VISN 2 ($180.3 million across 246 awards), and VISN 22 ($95.7 million across 197 awards). Outside the VA system, the Indian Health Service represents the largest customer by award count (728 awards, $85.5 million potential value), followed by the Navy Bureau of Medicine and Surgery (450 awards, $60.6 million) and the Army Medical Command (332 awards, $72.4 million).

The vendor's contract vehicle footprint is dominated by GSA Federal Supply Schedules and blanket purchase agreements structured as cost-per-reportable-result or cost-per-kit arrangements. The Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) is the primary vehicle, generating 2,444 task orders valued at $1.31 billion. Two additional GSA schedules—V797P4767A and V797P6580A—account for 1,703 and 919 task orders respectively, valued at $257.8 million and $23 million. The vendor also holds single-award and multiple-award indefinite delivery contracts with the Defense Logistics Agency, Indian Health Service, and individual Veterans Integrated Service Networks. Recent representative prime awards include a $1.29 billion ceiling BPA with VISN 12 for chemistry and immunochemistry cost-per-reportable-result testing (August 2026), a $603.8 million BPA with VISN 19 for blood gas testing through July 2031, and a $1.88 billion BPA with VISN 22 for RapidPoint and EPOC blood gas analyzer systems through May 2031 with four one-year renewal options.

Siemens' transaction profile reflects high transaction velocity at modest individual order sizes: the bulk of awards are small purchase orders and delivery orders for reagents, cartridges, consumables, and analyzer maintenance issued under standing BPA and schedule vehicles. The vendor supplies named equipment including Dimension EXL chemistry analyzers, Siemens Atellica laboratory systems, EPOC blood gas analyzers, RapidPoint systems, coagulation analyzers, PFA-100 platelet function analyzers, immunoassay equipment, and associated cartridges and reagents. Service content includes preventive maintenance, emergency repair, calibration, quality control, operator training, and point-of-care middleware integration across VA medical centers, Indian Health Service facilities, and Defense Health Agency installations.

Service Contract Inventory reporting captures a narrow slice of the vendor's federal services activity: SCI shows $11.1 million invoiced across 32 prime contracts (FY2022–FY2025), with FY2024 peaking at $5.2 million across 2.3 full-time equivalents. Median government-paid rates on SCI-reportable services reached $5,213.84 per hour, with 90th-percentile rates at $7,053.63 per hour, reflecting specialist labor for analyzer validation, migration, and technical support. The vendor reports minimal sub-engagement, with subcontractors accounting for an average three percent of contractor hours across prime contracts and only two named subcontractors reported across the entire SCI dataset. This profile indicates Siemens performs substantially all federal service delivery internally rather than through a network of subcontractors.

Recompete exposure is limited: 68 awards (combined potential value $18.5 million) reach ultimate completion within the next twenty-four months. The vendor holds one federal grant sub-award under the University of Utah as prime recipient (November 2023) for a multi-center implementation and validation study of magnetic resonance imaging analysis of atherosclerotic cervical carotid disease, indicating minimal grant participation. The vendor's federal posture is characterized by high transaction volume, customer concentration within the VA system, exclusive operation through GSA schedules and agency-specific blanket purchase agreements, and minimal subcontract engagement—reflecting a vertically integrated business model supplying diagnostic equipment and reagents directly to federal healthcare operations.